Clinical Trial Update: Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder [Phase 2]

View source ↗

Summary

This document reports the completion and results posting of a Phase 2 clinical trial evaluating the efficacy and safety of quetiapine extended-release (FK949E) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Quetiapine Extended Release (XR) (quetiapine)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-08-28